Our assets are unmatched. Indiana is uniquely positioned to support both large pharma organizations and smaller biotech companies with its concentration of more than 40 biopharma contract service providers. From formulation to toxicology to pharmacokinetics to manufacturing, a workforce of more than 8,200 people excels in specialized and sophisticated drug development services.

Indiana develops the drugs that improve patients' lives around the world.